Burning Rock Biotech Operating Expenses Growth & History (BNR)
Burning Rock Biotech's operating expenses was $65.5M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $65.5M | −$33.2M | −33.63% |
| 2024 | 2024-12-31 | $98.6M | −$46.8M | −32.18% |
| 2023 | 2023-12-31 | $145.4M | −$51.8M | −26.27% |
| 2022 | 2022-12-31 | $197.2M | $15.0M | +8.25% |
| 2021 | 2021-12-31 | $182.2M | $70.9M | +63.70% |
| 2020 | 2020-12-31 | $111.3M | — | — |
Burning Rock Biotech operating expenses trends
Over the last five fiscal years, Burning Rock Biotech's operating expenses decreased from $111.3M to $65.5M, a change of −$45.9M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗